Bone Scan With SPECT/CT Demonstrated C1 to C2 Involvement in Rheumatic Arthritis

An 80-year-old man was treated with rituximab for active rheumatoid arthritis until 2019, now controlled with Salazopyrin, prednisolone, methotrexate, and folic acid. However, laboratory data showed elevated C-reactive protein and erythrocyte sedimentation rate. Whole-body bone scan showed bony and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Tzyy-Ling, Chou, Shih-Chin, Chen, Yu-Ruei, Wang, Yuh-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169756/
https://www.ncbi.nlm.nih.gov/pubmed/35452005
http://dx.doi.org/10.1097/RLU.0000000000004160
Descripción
Sumario:An 80-year-old man was treated with rituximab for active rheumatoid arthritis until 2019, now controlled with Salazopyrin, prednisolone, methotrexate, and folic acid. However, laboratory data showed elevated C-reactive protein and erythrocyte sedimentation rate. Whole-body bone scan showed bony and joint destruction to the upper cervical vertebra (C spine), bilateral shoulders, wrists, finger joints, ankles, and left knee. SPECT/CT localized the upper C spine uptake to the C1/C2 joint and adjacent C1 and C2 with C1/C2 subluxation. C spine CT showed vertical atlantoaxial subluxation and bony erosions.

Ejemplares similares